Thromb Haemost 2002; 88(02): 356-357
DOI: 10.1055/s-0037-1613211
Letters to the Editor
Schattauer GmbH

cDNA Cloning and Tissue Distribution of the Rat Ortholog of Tissue Factor Pathway Inhibitor-2

Toru Hisaka
1   Groupe de Recherches pour l’Etude du Foie, INSERM E9917, Université Victor Segalen Bordeaux 2, Bordeaux, France
,
Walter Kisiel
2   Department of Pathology, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA
,
Jean Rosenbaum
1   Groupe de Recherches pour l’Etude du Foie, INSERM E9917, Université Victor Segalen Bordeaux 2, Bordeaux, France
› Author Affiliations
Supported by a grant from Comité de la Dordogne from the Ligue Nationale Contre le Cancer.
Further Information

Publication History

Received 01 February 2002

Accepted after resubmission 15 April 2002

Publication Date:
07 December 2017 (online)

 

 
  • References

  • 1 Petersen LC, Sprecher CA, Foster DC, Blumberg H, Hamamoto T, Kisiel W. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor. Biochemistry 1996; 35: 266-72.
  • 2 Miyagi Y, Yasumitsu H, Mizushima H, Koshikawa N, Matsuda Y, Itoh H, Hori TA, Aoki I, Miyazaki K. Cloning of the cDNA encoding mouse PP5/TFPI-2 and mapping of the gene to chromosome 6. DNA Cell Biol 1996; 15: 947-54.
  • 3 Kamei S, Petersen LC, Sprecher CA, Foster DC, Kisiel W. Inhibitory properties of human recombinant Arg24→Gln type-2 tissue factor pathway inhibitor (R24Q TFPI-2). Thromb Res 1999; 94: 147-52.
  • 4 Rao CN, Cook B, Liu Y, Chilukuri C, Stack MS, Foster DC, Kisiel W, Woodley DT. HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI. Int J Cancer 1998; 76: 749-56.
  • 5 Neaud V, Hisaka T, Monvoisin A, Bedin C, Balabaud C, Foster DC, Desmoulière A, Kisiel W, Rosenbaum J. Paradoxical proinvasive effect of the serine proteinase inhibitor tissue factor pathway inhibitor-2 on human hepatocellular carcinoma cells. J Biol Chem 2000; 275: 35565-9.